The South African Health Products Regulatory Authority announced on Thursday that South Africa has recorded a fatality linked to coronavirus vaccination.
It said that the person died following immunisation with the Johnson & Johnson COVID-19 vaccine.
Saphra said that due to patient confidentiality, no details regarding the case may be shared.
The patient was diagnosed with Guillain-Barré Syndrome, also referred to a GBS, which is a rare disorder where the body’s immune system damages the nervous system.
Sahpra CEO, Doctor Boitumelo Semete-Makokotlela: “It is with very sad hearts today that we report to you that Sahpra has been informed of a fatal case of a sydrom called Guillain-Barré Syndrome, shortly referred to as GBS. This is a case that was noted following vaccination with the COVID-19 Janssen vaccine.”
More Stories
Arts Project Aimed At Preserving South African Culture
Ten Struggles Domestic Workers Face
Godongwana Harassment Claims Set To Be Discussed By ANC Integrity Commission
Eskom Cuts Illegal Connections In Cape Town
Mabuyane Rewards Loyalists
National Lotteries Commissioner Mampane Resigns
Solid Improvement In SA Business Debt Conditions in Q1 – Experian Data
Joburg Film Festival To Return In 2023
Amcu Marks 10th anniversary Of Marikana Massacre
Supreme Court Of Appeal Reserves Judgment In Zuma Matter
ANCWL Calls For Swift Action On Claims Against Godongwana
No Need To Panic Over Fourth Monkeypox Case – Dhlomo